Ionis Pharmaceuticals Inc
IONSNASDAQStock · Data from SEC EDGAR 13F · Held by 8 of 87 tracked investors
Ionis Pharmaceuticals Inc at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation15
- Growth66
- Profitability5
- Quality20
- Debt15
- Stability38
- ✓Revenue grew 17.1% a year over 3 years.
- ✓The analysts' average target is 91% above the price.
- !The company is loss-making: net profit is negative.
- !Free cash flow is negative and the company has debt.
- !In some year revenue fell sharply.
The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.
Is the stock expensive?
ExpensiveThe company has no earnings, so the P/E cannot be calculated.
- P/E
- –
- P/S
- 8.4×
- EV/EBITDA
- -12.6×
Is the company growing?
GrowingRevenue over 3 years grew 17.1% a year. Last year -40.7%.
Does it make money?
Loss-makingEarnings results
| Quarter | Reported | EPS | Analyst estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | 29 Jul 2026 | -0.70 | -1.09 | +35.8% |
| Mar 2026 | 29 Apr 2026 | -0.56 | -0.89 | +37.1% |
| Dec 2025 | 25 Feb 2026 | -1.41 | -1.31 | -7.6% |
| Sep 2025 | 29 Oct 2025 | -0.80 | -1.23 | +35% |
EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.
Chart IONS
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
8TB Tweedy Browne Tweedy, Browne Company | 13.7% |
CW Cathie Wood ARK Investment Management | 0.15% |
JS Jim Simons Renaissance Technologies | 0.06% |
JG Joel Greenblatt Gotham Asset Management | 0.02% |
Šn Švýcarská národní banka Swiss National Bank | 0.01% |
RB Ron Baron Baron Capital | 0% |
KF Ken Fisher Fisher Investments | 0% |
Ns Norský státní fond Norges Bank | 0% |
Frequently asked questions
How much is Ionis Pharmaceuticals Inc (IONS) stock?
Ionis Pharmaceuticals Inc shares trade at $43.96, +1.24% over the last trading day. The price is delayed.
What is the market cap of Ionis Pharmaceuticals Inc?
The market cap of Ionis Pharmaceuticals Inc is about $7.3B.
Which big investors hold Ionis Pharmaceuticals Inc?
According to the latest 13F filings, 8 of 87 tracked investors hold Ionis Pharmaceuticals Inc, for example Tweedy Browne, Cathie Wood, Jim Simons.
When will Ionis Pharmaceuticals Inc report its next results?
The next earnings report of Ionis Pharmaceuticals Inc is expected on 4 Nov 2026.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.